Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia 15Lymphoma 11Burkitt Lymphoma 9Leukemia, Biphenotypic, Acute 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Large-Cell, Anaplastic 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasm, Residual 2Lymphoma, Large-Cell, Immunoblastic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Down Syndrome 2Recurrence 1Philadelphia Chromosome 1Neurotoxicity Syndromes 1Neoplasms 1Mediastinal Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, T-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphoid 1Leukemia, B-Cell 1Immunoblastic Lymphadenopathy 1Drug-Related Side Effects and Adverse Reactions 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cytarabine 5Vincristine 3Thioguanine 3Methotrexate 3Mercaptopurine 3Daunorubicin 3Cyclophosphamide 3prednylidene 2pegaspargase 2merphos 2dexamethasone acetate 2dexamethasone 21-phosphate 2azathiopurine 2auricularum 2asparaginase erwinia chrysanthemi recombinant 2Prednisolone 2Leucovorin 2Etoposide 2Doxorubicin 2Dexamethasone 2Calcium Dobesilate 2Asparaginase 2deltacortene 1blinatumomab 1Radiotherapy 1Radiation 1Prednisone 1N,N-dicyclohexyl-isoborneol-10-sulfonamide 1Mitoxantrone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Down Syndrome × Prednisolone × Other hematologic neoplasm × Clear all
NCT03914625 2026-05-27

A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 3 Active not recruiting
6,720 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

NCT03286634 2026-05-11

ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016

National Hospital Organization Nagoya Medical Center

Phase 2 Active not recruiting
60 enrolled
LymphoidOther hematologic neoplasm

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡